Author
Listed:
- Xiang Yu
(Wuhan National Laboratory for Optoelectronics-Huazhong University of Science and Technology
Huazhong University of Science and Technology)
- Lu Chen
(Wuhan National Laboratory for Optoelectronics-Huazhong University of Science and Technology
Huazhong University of Science and Technology)
- Jianqiao Liu
(Wuhan National Laboratory for Optoelectronics-Huazhong University of Science and Technology
Huazhong University of Science and Technology)
- Bolei Dai
(Wuhan National Laboratory for Optoelectronics-Huazhong University of Science and Technology
Huazhong University of Science and Technology)
- Guoqiang Xu
(Wuhan National Laboratory for Optoelectronics-Huazhong University of Science and Technology
Huazhong University of Science and Technology)
- Guanxin Shen
(Huazhong University of Science and Technology)
- Qingming Luo
(Wuhan National Laboratory for Optoelectronics-Huazhong University of Science and Technology
Huazhong University of Science and Technology)
- Zhihong Zhang
(Wuhan National Laboratory for Optoelectronics-Huazhong University of Science and Technology
Huazhong University of Science and Technology)
Abstract
Liver sinusoidal endothelial cells (LSECs) are responsible for the immunologic tolerance of liver which is a common site for visceral metastases, suggesting its potential role as an target for cancer immunotherapy. However, targeted modulation of LSECs is still not achieved thus far. Here, we report LSECs are specifically targeted and modulated by melittin nanoparticles (α-melittin-NPs). Intravital imaging shows that LSECs fluoresce within 20 s after intravenous injection of α-melittin-NPs. α-melittin-NPs trigger the activation of LSECs and lead to dramatic changes of cytokine/chemokine milieu in the liver, which switches the hepatic immunologic environment to the activated state. As a result, α-melittin-NPs resist the formation of metastatic lesions with high efficiency. More strikingly, the survival rate reaches 80% in the spontaneous liver metastatic tumor model. Our research provides support for the use of α-melittin-NPs to break LSEC-mediated immunologic tolerance, which opens an avenue to control liver metastasis through the immunomodulation of LSECs.
Suggested Citation
Xiang Yu & Lu Chen & Jianqiao Liu & Bolei Dai & Guoqiang Xu & Guanxin Shen & Qingming Luo & Zhihong Zhang, 2019.
"Immune modulation of liver sinusoidal endothelial cells by melittin nanoparticles suppresses liver metastasis,"
Nature Communications, Nature, vol. 10(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-08538-x
DOI: 10.1038/s41467-019-08538-x
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-08538-x. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.